GSK 4716 - CAS 101574-65-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C17H18N2O2
Molecular Weight:
282.34
COA:
Inquire
Targets:
Estrogen Receptor/ERR
Description:
GSK 4716 is a selective agonist of estrogen-related receptors ERRβ and ERRγ displaying selectivity over ERRα and the classical estrogen receptors. Activation of GSK 4716 regulates mitochondrial activity in skeletal muscle during exercise.
Brife Description:
ERRβ/γ agonist
Purity:
≥99% by HPLC
Synonyms:
4-Hydroxy-2-[(1E)-[4-(1-methylethyl)phenyl]methylene]hydrazide
MSDS:
Inquire
InChIKey:
IKPPIUNQWSRCOZ-WOJGMQOQSA-N
InChI:
InChI=1S/C17H18N2O2/c1-12(2)14-5-3-13(4-6-14)11-18-19-17(21)15-7-9-16(20)10-8-15/h3-12,20H,1-2H3,(H,19,21)/b18-11+
Canonical SMILES:
CC(C)C1=CC=C(C=C1)C=NNC(=O)C2=CC=C(C=C2)O
1.ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease.
Nakano M;Imamura H;Sasaoka N;Yamamoto M;Uemura N;Shudo T;Fuchigami T;Takahashi R;Kakizuka A EBioMedicine. 2017 Aug;22:225-241. doi: 10.1016/j.ebiom.2017.07.024. Epub 2017 Jul 25.
Parkinson's disease is assumed to be caused by mitochondrial dysfunction in the affected dopaminergic neurons in the brain. We have recently created small chemicals, KUSs (Kyoto University Substances), which can reduce cellular ATP consumption. By contrast, agonistic ligands of ERRs (estrogen receptor-related receptors) are expected to raise cellular ATP levels via enhancing ATP production. Here, we show that esculetin functions as an ERR agonist, and its addition to culture media enhances glycolysis and mitochondrial respiration, leading to elevated cellular ATP levels. Subsequently, we show the neuroprotective efficacies of KUSs, esculetin, and GSK4716 (an ERRγ agonist) against cell death in Parkinson's disease models. In the surviving neurons, ATP levels and expression levels of α-synuclein and CHOP (an ER stress-mediated cell death executor) were all rectified. We propose that maintenance of ATP levels, by inhibiting ATP consumption or enhancing ATP production, or both, would be a promising therapeutic strategy for Parkinson's disease.
2.Estrogen-related receptors as emerging targets in cancer and metabolic disorders.
Ariazi EA;Jordan VC Curr Top Med Chem. 2006;6(3):203-15.
While estrogen receptor (ER)-targeted therapeutics have clearly been a success in the treatment of breast cancer, the orphan estrogen-related receptors (ERRs) represent novel targets for future development. The ERRs, comprising ERRalpha, ERRbeta and ERRgamma, bind and regulate transcription via estrogen response elements (EREs) and extended ERE half-sites termed ERR response elements (ERREs), but do not bind endogenous estrogens. The emerging role of ERRalpha and ERRgamma in modulating estrogen responsiveness, substituting for ER activities, and serving as prognosticators in breast and other cancers is providing an impetus for the identification of compounds which target these proteins. Moreover, ERRalpha plays a role in energy homeostasis and will likely be targeted for the treatment of metabolic disorders. Multiple classes of synthetic ligands have already been identified. The phytoestrogens genistein, daidzein, biochanin A and 6,3'4'-tryhydroxyflavone have been reported as ERRalpha agonists. The phenolic acyl hydrazones GSK4716 and GSK9089 act as selective agonists of ERRbeta and ERRgamma. The organochlorine pesticides toxaphene and chlordane, and the synthetic compound XCT790 antagonize ERRalpha.
3.Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma.
Song G;Wang L Nucleic Acids Res. 2008 Oct;36(18):5727-35. doi: 10.1093/nar/gkn567. Epub 2008 Sep 6.
MicroRNAs (miRNAs, miRs) are genomically encoded small approximately 22 nt RNA molecules that have been shown to mediate translational repression of target mRNAs involved in cellular proliferation, differentiation and death. Despite intensive studies on their physiological and pathological functions, the molecular mechanism of how miRNA gene transcription is regulated remains largely unknown. Microarray profiling revealed 21 miRNAs clustered on chromosome 12, including miR-433 and miR-127, that were co-upregulated in small heterodimer partner (SHP, NR0B2) SHP knockouts (SHP(-/-)) liver. Gene cloning revealed that the 3'-coding region of pri-miR-433 served as the promoter region of pri-miR-127. Estrogen related receptor (ERRgamma, NR3B3) robustly activated miR-433 and miR-127 promoter reporters through ERRE, which was transrepressed by SHP. The strong elevation of miR-433 and miR-127 in Hepa-1 cells correlated with the down-regulation of SHP and up-regulation of ERRgamma. Ectopic expression of ERRgamma induced miR-433 and miR-127 expression, which was repressed by SHP coexpression. In contrast, knockdown ERRgamma decreased miR-433 and miR-127 expression. In addition, the ERRgamma agonist GSK4716 induced miR-433 and miR-127 expression both in vitro and in vivo, respectively.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Estrogen Receptor/ERR Products


CAS 524047-78-7 (R)-DPN

(R)-DPN
(CAS: 524047-78-7)

(R)-DPN has been found to be an estrogen receptor (ER) β agonist with higher affinity for estrogen receptor.

CAS 434-03-7 Ethisterone

Ethisterone
(CAS: 434-03-7)

Ethisterone is a progestogen hormone being considered to treat prostate cancer.It was the first orally-active progestin.

CAS 129453-61-8 Fulvestrant

Fulvestrant
(CAS: 129453-61-8)

Fulvestrant is an effective inhibitor of the growth of ER-positive MCF-7 (with IC50 of 0.29 nM) but with no effect on the growth of ER-negative BT-20 human brea...

CAS 722533-56-4 Elacestrant

Elacestrant
(CAS: 722533-56-4)

Elacestrant, also referred to RAD1901, is a selective and orally available estrogen receptor (ERR) degrader (IC50= 48 and 870 nM for ERα and ERβ, respectively) ...

CAS 88431-47-4 Clomoxir

Clomoxir
(CAS: 88431-47-4)

Clomoxir is a carnitine O-palmitoyltransferase inhibitor.

CAS 198481-32-2 Bazedoxifene

Bazedoxifene
(CAS: 198481-32-2)

Bazedoxifene is a selective estrogen receptor modulator (SERM) currently in development for osteoporosis prevention and treatment.

CAS 151555-47-4 RU 58668

RU 58668
(CAS: 151555-47-4)

RU 58668 is a pure antiestrogen that downregulates estrogen receptor expression (IC50 = 0.04 nM). It has been shown to display potent antiproliferative activity...

CAS 1197194-41-4 Endoxifen hydrochloride

Endoxifen hydrochloride
(CAS: 1197194-41-4)

Endoxifen hydrochloride is a metabolite of Tamoxifen and a selective estrogen receptor modulator (SERM) that inhibits the growth of estrogen-stimulated BT474 ce...

CAS 50-50-0 Estradiol Benzoate

Estradiol Benzoate
(CAS: 50-50-0)

Estradiol benzoate is an estradiol analog which binds to the human, murine and chicken ERα with IC50 of 22-28 nM.

CAS 68047-06-3 (Z)-4-Hydroxytamoxifen

(Z)-4-Hydroxytamoxifen
(CAS: 68047-06-3)

(Z)-4-Hydroxytamoxifen is a metabolite of Tamoxifen and acts as an estrogen receptor antagonist. It exhibits more than 100-fold affinity over Tamoxifen. (Z)-4-H...

CAS 82640-04-8 Raloxifene HCl

Raloxifene HCl
(CAS: 82640-04-8)

Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It ...

CAS 1365888-06-7 GDC-0810 (ARN-810)

GDC-0810 (ARN-810)
(CAS: 1365888-06-7)

GDC-0810, also known as ARN-810 and RG6046, an orally bioavailable Selective Estrogen Receptor Degrader (SERD) that demonstrates robust activity in tamoxifen-re...

CAS 486-66-8 Daidzein

Daidzein
(CAS: 486-66-8)

Daidzein belongs to the group of isoflavones.Daidzein can be converted to its end metabolite S-equol in some humans based on the presence of certain intestinal ...

CAS 7599-79-3 trans-Clomiphene Citrate

trans-Clomiphene Citrate
(CAS: 7599-79-3)

Enclomiphene citrateis a non-steroidal estrogen receptor antagonist. It can be used for secondary hypogonadism in overweight men wishing to restore normal testi...

CAS 54965-24-1 Tamoxifen Citrate

Tamoxifen Citrate
(CAS: 54965-24-1)

Tamoxifen Citrate is an antagonist of the estrogen receptor by competitive inhibition of estrogen binding, leading to a reduction in DNA synthesis and cellular ...

CAS 1847-63-8 Nafoxidine HCl

Nafoxidine HCl
(CAS: 1847-63-8)

Nafoxidine HCl is the hydrochloride salt of nafoxidine. Nafoxidine, structurally related to Tamoxifen, is a non-steroidal partial estrogen antagonist.

CAS 245124-69-0 Pipendoxifene hydrochloride

Pipendoxifene hydrochloride
(CAS: 245124-69-0)

Pipendoxifene hydrochloride is the hydrochloride salt of Pipendoxifene which

CAS 182133-25-1 Arzoxifene

Arzoxifene
(CAS: 182133-25-1)

Arzoxifene, also known as LY353381, a synthetic aromatic derivative with anti-estrogenic properties, displays greater bioavailability and higher anti-estrogenic...

CAS 979-32-8 Estradiol valerate

Estradiol valerate
(CAS: 979-32-8)

Estradiol valerate is a synthetic ester, specifically the 17-pentanoyl ester, of the natural estrogen, 17β-estradiol. It was introduced in the 1950s, and a...

CAS 529-59-9 Genistin

Genistin
(CAS: 529-59-9)

Genistin is a derivative of Genistein, which is a PTK inhibitor. Genistin acts as a selective estrogen receptor modulator (SERM). It increases growth of breast ...

Chemical Structure

CAS 101574-65-6 GSK 4716

Quick Inquiry

Verification code

Featured Items